Tocilizumab Reduces Need for Mechanical Ventilation in COVID-19 Pneumonia Trial By Brian Park, PharmD Publish Date September 21, 2020
Transdermal Cannabidiol Gets Orphan Drug Status for 22q11.2 Deletion Syndrome By Brian Park, PharmD Publish Date September 18, 2020
FDA to Review Avacopan for ANCA-Associated Vasculitis By Brian Park, PharmD Publish Date September 18, 2020
Empagliflozin Fast Tracked for Improving Outcomes Following Myocardial Infarction By Brian Park, PharmD Publish Date September 16, 2020
New Drug Application for Apomorphine Infusion Pump Submitted for Review By Brian Park, PharmD Publish Date September 16, 2020
Baricitinib Plus Remdesivir Cuts Time to Recovery for Hospitalized COVID-19 Patients By Brian Park, PharmD Publish Date September 15, 2020
FDA Rejects Terlipressin NDA for Hepatorenal Syndrome Type 1 By Brian Park, PharmD Publish Date September 14, 2020
Dupilumab Gets Breakthrough Therapy Status for Eosinophilic Esophagitis By Brian Park, PharmD Publish Date September 14, 2020
FDA to Review Investigational Rosacea Treatment Epsolay By Brian Park, PharmD Publish Date September 14, 2020
Benralizumab Looks Promising in Nasal Polyps Trial By Brian Park, PharmD Publish Date September 11, 2020
FDA Fast Tracks SSAO Inhibitor for Nonalcoholic Steatohepatitis By Brian Park, PharmD Publish Date September 11, 2020
Statistically Significant Reduction in Cough Frequency Observed in Gefapixant Trials By Brian Park, PharmD Publish Date September 10, 2020
Pimodivir Influenza Development Program Discontinued By Brian Park, PharmD Publish Date September 3, 2020
Phase 3 Trial Investigating COVID-19 Vaccine Candidate AZD1222 Begins By Brian Park, PharmD Publish Date September 2, 2020
Evolocumab Cuts LDL-C in Pediatric HeFH Patients By Brian Park, PharmD Publish Date September 1, 2020
Consistent LDL-C Lowering Reported With Twice-Yearly Inclisiran By Brian Park, PharmD Publish Date August 31, 2020
Tapinarof Cream Looks Promising for Plaque Psoriasis By Brian Park, PharmD Publish Date August 27, 2020
Casimersen Gets Priority Review for Duchenne Muscular Dystrophy By Brian Park, PharmD Publish Date August 26, 2020
Upadacitinib Application for Ankylosing Spondylitis Submitted for Review By Brian Park, PharmD Publish Date August 26, 2020
Tepotinib Gets Priority Review for Metastatic NSCLC With METex14 Skipping Mutation By Brian Park, PharmD Publish Date August 26, 2020
